The property developers behind Cleveland Clinic‘s 364-bed hospital in Abu Dhabi project that the hospital will open to patients in the fourth quarter of 2013.
The final phase of construction is due for completion and handover in the second quarter of 2013, with the opening scheduled for later in the year, according to a statement from Mubadala Healthcare, the property developer that will own the hospital. Cleveland Clinic will operate the hospital.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
A late 2013 opening date for the hospital represents a significant departure from the original time line set out when the project was announced in 2006. At that time, the Clinic and Mubadala said the hospital was scheduled to be “operational” in three years.
A Cleveland Clinic spokesman said initial plans, which have since been scrapped, called for the Abu Dhabi facility to open in a two-stage process: first to provide outpatient care, and then, later for inpatient care. The original time line referred to the outpatient opening.
Now, the plan is to open Cleveland Clinic Abu Dhabi for both inpatient and outpatient care at the same time next year, the spokesman said.
The hospital, which will be expandable from 364 beds to 490, will be organized into five institutes: digestive disease, eye, heart and vascular, neurological, and respiratory and critical care.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The Clinic’s former chief medical operation officer, Marc Harrison, was last year appointed as CEO of the Abu Dhabi hospital. Joining him on the leadership team will be Dr. Tomislav Mihaljevic as chairman of the Heart and Vascular Institute.
The Abu Dhabi location is Cleveland Clinic’s first outside of North America.
